<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01508143</url>
  </required_header>
  <id_info>
    <org_study_id>Misoprostol in termination</org_study_id>
    <nct_id>NCT01508143</nct_id>
  </id_info>
  <brief_title>Comparitive Study of Two Misoprostol Regimen in Early Pregnancy Termination</brief_title>
  <official_title>A Comparative Study of Vaginal Misoprostol Two Dosing Regimen for First Trimester Pregnancy Termination in Patients Admitted at Bandarabbas in Shariati Hospital in 2009</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hormozgan University of Medical Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hormozgan University of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to compare two misoprostol regimen in pregnancy termination.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Studies on determining the optimal dosage for misoprostol in pregnancy termination are
      continuing and still there is no evidence for ideal misoprostol regimen for pregnancy
      termination. The aim of this study is to compare two misoprostol regimen in pregnancy
      termination.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Abortion</measure>
    <time_frame>48 hours after treatment</time_frame>
    <description>After 48 hours after treatment each patient is assessed for abortion. Patients are devided into three groups including complete, partial or no abortion.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of abortion</measure>
    <time_frame>Form the begining of treatment to complete abortion</time_frame>
    <description>Duration of abortion Form the begining of treatment to complete abortion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse Effects</measure>
    <time_frame>48 hours after treatment</time_frame>
    <description>including nausea, vomiting, fever and chill, diarhea, abdominal cramp, skin rash</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Need for surgery</measure>
    <time_frame>48 hours after treatment</time_frame>
    <description>Dilatation &amp; cartage</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">41</enrollment>
  <condition>Termination</condition>
  <arm_group>
    <arm_group_label>400 microgram misoprostol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>400 micrograms misoprostol each 6 hours for 8 dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>800 micrograms misoprostol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>800 micrograms misoprostol each 12 hours for 4 dose</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol 400 micrograms</intervention_name>
    <description>Misoprostol 400 micrograms each 6 hours for 8 dose</description>
    <arm_group_label>400 microgram misoprostol</arm_group_label>
    <other_name>Cytotec</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Misoprostol 800 micrograms</intervention_name>
    <description>Misoprostol 800 micrograms each 12 hours for 4 doses</description>
    <arm_group_label>800 micrograms misoprostol</arm_group_label>
    <other_name>Cytotec</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All women who were candidates for early pregnancy termination because of fetal death
             or other medical conditions

          -  Before 14th week of gestation calculated according LMP or first trimester sonography

        Exclusion Criteria:

          -  Chorioamnionitis

          -  Hypersensitivity to prosstaglandins

          -  Past medical history of cardiovascular, kidney or liver or lung diseases

          -  Positive history for uterus pathologies

          -  suspicious to extra-uterus pregnancy

          -  sign and symptoms of uterus infection

          -  Molar pregnancy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hormozgan University of Medical Sciences</name>
      <address>
        <city>Bandar Abbas</city>
        <state>Hormozgan</state>
        <zip>097145-3388</zip>
        <country>Iran, Islamic Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iran, Islamic Republic of</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 9, 2012</study_first_submitted>
  <study_first_submitted_qc>January 9, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2012</study_first_posted>
  <last_update_submitted>September 30, 2012</last_update_submitted>
  <last_update_submitted_qc>September 30, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hormozgan University of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Hamidreza Mahboobi</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <keyword>Abortion</keyword>
  <keyword>Pregnancy</keyword>
  <keyword>Termination</keyword>
  <keyword>Misoprostol</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Misoprostol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

